Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine if non-opioid pain control is a safe way to manage
pain after intracapsular adenotonsillectomy surgery in children. This study is the second
part of our randomized clinical trials of assessing pain after adenotonsillectomy (T&A), the
first being total T&A. The investigators will repeat the methodology in the first clinical
trial by randomly assigning children aged 3-17 to one of two groups: one group will receive
non-opioid pain medication only, and the other group will receive opioid and non-opioid
medications for pain control. The investigators will analyze the data and determine if there
is a difference in pain control between the two drug regimens, and if there are any other
associated complications between the two groups.
This study is important because if we can demonstrate that there is little difference in
outcomes and pain control between the two groups, a strong argument can be made for reducing
or eliminating opioid prescription after intracapsular adenotonsillectomy. This may protect
future children from the risks of taking opioid medications and help to reduce the scope of
the opioid epidemic.